Technical Resources International, INC.

UEI FAA2LVENETH4 · MD · SAM.gov record ↗

$130.9M

FY2025 obligations

Contract awards

Jun 30, 2015

First action

Jul 1, 2026

Latest action

Obligations by agency

Department Of Health And Human Services$130.9M
General Services Administration$0

Obligations by NAICS

Monthly obligations

Oct 24

Nov 24

Dec 24

Jan 25

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Contracts ending within 18 months (recompete watch)

75N95025F00001 ↗$442K
PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I SINGLE ASCENDING DOSE STUDY. MAY 15, 2025 - NOVEMBER 14, 2026. N01DA-25-8947. TASK ORDER 75N95025F00001 (TO1).
Ends
Nov 13, 2026
Started
May 14, 2025
Agency
National Institutes Of Health
NAICS
541715
75N98026F00001 ↗$11K
TASK ORDER 4. PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE III PROTOCOL (STP7). JUNE 5, 2026 - MARCH 4, 2027. N01DA-25-8947. TASK ORDER 75N98026F00001 (TO2).
Ends
Mar 3, 2027
Started
Jun 4, 2026
Agency
National Institutes Of Health
NAICS
541715
75N95024F00001 ↗$34K
CHANGE ORDER. PHASE I SINGLE ASCENDING DOSE STUDY. TO7. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 09/10/2024 - 03/09/2026. NIDA REF. NO. N01DA-19-8947.
Ends
Mar 7, 2027
Started
Sep 9, 2024
Agency
National Institutes Of Health
NAICS
541715
75N93023F00001 ↗$569K
REGULATORY OPERATIONS SUPPORT SERVICES
Ends
Mar 29, 2027
Started
Mar 30, 2023
Agency
National Institutes Of Health
NAICS
541714
75N93024C00004 ↗$47.3M
CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS)
Ends
Mar 30, 2027
Started
Mar 31, 2024
Agency
National Institutes Of Health
NAICS
541715
75N93024F00001 ↗$36.7M
NIAID/DAIDS REGULATORY SUPPORT CENTER
Ends
Apr 13, 2027
Started
Apr 14, 2024
Agency
National Institutes Of Health
NAICS
541714
75N93025F00001 ↗$5.8M
DAIDS QUALITY ASSURANCE, QUALITY CONTROL AND INSPECTION READINESS SUPPORT SERVICES
Ends
Apr 15, 2027
Started
Apr 16, 2025
Agency
National Institutes Of Health
NAICS
541714
75N93022C00010 ↗$7.4M
REGULATORY AFFAIRS SUPPORT
Ends
Jun 29, 2027
Started
Jun 30, 2022
Agency
National Institutes Of Health
NAICS
541715
75N91022C00014 ↗$16.2M
DRUG DEVELOPMENT SUPPORT FOR CTEP
Ends
Jun 29, 2027
Started
Jun 30, 2022
Agency
National Institutes Of Health
NAICS
541715
75N91021C00013 ↗$19.4M
CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.
Ends
Jun 29, 2027
Started
Jun 30, 2021
Agency
National Institutes Of Health
NAICS
541715

PIID	Description	Agency	NAICS	Obligated	Start	End
75N95025F00001 ↗	PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I SINGLE ASCENDING DOSE STUDY. MAY 15, 2025 - NOVEMBER 14, 2026. N01DA-25-8947. TASK ORDER 75N95025F00001 (TO1).	National Institutes Of Health	541715	$442K	May 14, 2025	Nov 13, 2026
75N98026F00001 ↗	TASK ORDER 4. PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE III PROTOCOL (STP7). JUNE 5, 2026 - MARCH 4, 2027. N01DA-25-8947. TASK ORDER 75N98026F00001 (TO2).	National Institutes Of Health	541715	$11K	Jun 4, 2026	Mar 3, 2027
75N95024F00001 ↗	CHANGE ORDER. PHASE I SINGLE ASCENDING DOSE STUDY. TO7. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 09/10/2024 - 03/09/2026. NIDA REF. NO. N01DA-19-8947.	National Institutes Of Health	541715	$34K	Sep 9, 2024	Mar 7, 2027
75N93023F00001 ↗	REGULATORY OPERATIONS SUPPORT SERVICES	National Institutes Of Health	541714	$569K	Mar 30, 2023	Mar 29, 2027
75N93024C00004 ↗	CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS)	National Institutes Of Health	541715	$47.3M	Mar 31, 2024	Mar 30, 2027
75N93024F00001 ↗	NIAID/DAIDS REGULATORY SUPPORT CENTER	National Institutes Of Health	541714	$36.7M	Apr 14, 2024	Apr 13, 2027
75N93025F00001 ↗	DAIDS QUALITY ASSURANCE, QUALITY CONTROL AND INSPECTION READINESS SUPPORT SERVICES	National Institutes Of Health	541714	$5.8M	Apr 16, 2025	Apr 15, 2027
75N93022C00010 ↗	REGULATORY AFFAIRS SUPPORT	National Institutes Of Health	541715	$7.4M	Jun 30, 2022	Jun 29, 2027
75N91022C00014 ↗	DRUG DEVELOPMENT SUPPORT FOR CTEP	National Institutes Of Health	541715	$16.2M	Jun 30, 2022	Jun 29, 2027
75N91021C00013 ↗	CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.	National Institutes Of Health	541715	$19.4M	Jun 30, 2021	Jun 29, 2027

Largest awards

75N93024C00004 ↗$47.3M
CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS)
Ends
Mar 30, 2027
Started
Mar 31, 2024
Agency
National Institutes Of Health
NAICS
541715
75N93024F00001 ↗$36.7M
NIAID/DAIDS REGULATORY SUPPORT CENTER
Ends
Apr 13, 2027
Started
Apr 14, 2024
Agency
National Institutes Of Health
NAICS
541714
75N91021C00013 ↗$19.4M
CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.
Ends
Jun 29, 2027
Started
Jun 30, 2021
Agency
National Institutes Of Health
NAICS
541715
75N91022C00014 ↗$16.2M
DRUG DEVELOPMENT SUPPORT FOR CTEP
Ends
Jun 29, 2027
Started
Jun 30, 2022
Agency
National Institutes Of Health
NAICS
541715
75N93022C00010 ↗$7.4M
REGULATORY AFFAIRS SUPPORT
Ends
Jun 29, 2027
Started
Jun 30, 2022
Agency
National Institutes Of Health
NAICS
541715
75N93025F00001 ↗$5.8M
DAIDS QUALITY ASSURANCE, QUALITY CONTROL AND INSPECTION READINESS SUPPORT SERVICES
Ends
Apr 15, 2027
Started
Apr 16, 2025
Agency
National Institutes Of Health
NAICS
541714
75N91022F00001 ↗$831K
TASK ORDER 1A -PROJECT KICKOFF MEETING AND TASK ORDER 5A: CENTRALIZED PROTOCOL WRITING SUPPORT; CONTRACT TITLE: CANCER TRIALS SUPPORT UNIT CTSU.
Ends
Jul 30, 2026
Started
Jul 31, 2022
Agency
National Institutes Of Health
NAICS
541715
75N93023F00001 ↗$569K
REGULATORY OPERATIONS SUPPORT SERVICES
Ends
Mar 29, 2027
Started
Mar 30, 2023
Agency
National Institutes Of Health
NAICS
541714
75N95025F00001 ↗$442K
PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I SINGLE ASCENDING DOSE STUDY. MAY 15, 2025 - NOVEMBER 14, 2026. N01DA-25-8947. TASK ORDER 75N95025F00001 (TO1).
Ends
Nov 13, 2026
Started
May 14, 2025
Agency
National Institutes Of Health
NAICS
541715
75N93022F00001 ↗$374K
'PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS (PTVDS)'
Ends
Aug 6, 2027
Started
Nov 30, 2021
Agency
National Institutes Of Health
NAICS
541715
75N94025F00001 ↗$294K
NICHD:R&D:DATA COORDINATING CENTER FOR PREPARATION, TRAINING ACTIVITIES, ENROLLMENT AND DATA COLLECTION AND DATA ANALYSIS OF THE SPAN STUDY:NON-SEVERABLE
Ends
Jul 30, 2026
Started
Jul 31, 2025
Agency
National Institutes Of Health
NAICS
541714
75N95025F00003 ↗$36K
PHARMACOKINETIC ANALYSIS RESOURCE CENTER. OTHER SUPPORT SERVICES. JULY 23, 2025 - JULY 22, 2026. N01DA-25-8947. TASK ORDER 75N95025F00003 (TO3).
Ends
Jul 21, 2026
Started
Jul 22, 2025
Agency
National Institutes Of Health
NAICS
541715
75N95024F00001 ↗$34K
CHANGE ORDER. PHASE I SINGLE ASCENDING DOSE STUDY. TO7. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 09/10/2024 - 03/09/2026. NIDA REF. NO. N01DA-19-8947.
Ends
Mar 7, 2027
Started
Sep 9, 2024
Agency
National Institutes Of Health
NAICS
541715
75N94019F00125 ↗$11K
NICHD:R&D:DATA COORDINATING CENTER FOR THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN):NON-SEVERABLE
Ends
Jul 30, 2025
Started
Sep 16, 2019
Agency
National Institutes Of Health
NAICS
541714
75N98026F00001 ↗$11K
TASK ORDER 4. PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE III PROTOCOL (STP7). JUNE 5, 2026 - MARCH 4, 2027. N01DA-25-8947. TASK ORDER 75N98026F00001 (TO2).
Ends
Mar 3, 2027
Started
Jun 4, 2026
Agency
National Institutes Of Health
NAICS
541715
75N95025F00002 ↗$11K
PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I CLINICAL PHARMACOLOGY/PHARMACOKINETIC STUDY. JULY 23, 2025 - JANUARY 22, 2026. N01DA-25-8947. TASK ORDER 75N95025F00002 (TO2).
Ends
Jul 30, 2026
Started
Jul 22, 2025
Agency
National Institutes Of Health
NAICS
541715
GS00F274CA ↗$0
FEDERAL SUPPLY SCHEDULE CONTRACT
Ends
—
Started
Sep 15, 2015
Agency
Federal Acquisition Service
NAICS
541620
75N93024F00002 ↗$0
DAIDS QUALITY ASSURANCE, QUALITY CONTROL AND INSPECTION READINESS SUPPORT SERVICES - CARRRP TASK AREA F
Ends
Apr 15, 2025
Started
Apr 16, 2024
Agency
National Institutes Of Health
NAICS
541714
75N91024P00361 ↗$0
CLINICAL TRIALS ACCRUAL QUALITY IMPROVEMENT PROGRAM (AQUIP) DATA AND INFORMATION TECHNOLOGY SUPPORT FOR THE US-LATIN AMERICAN-CARIBBEAN HIV/HPV PREVENTION CLINICAL TRIALS NETWORK (ULACNET)
Ends
Jun 1, 2025
Started
Jun 2, 2024
Agency
National Institutes Of Health
NAICS
541990
75N95022C00032 ↗$0
ACTIV-1 TIME-LIMITED BIOSPECIMEN STORAGE AND RELATED SERVICES (COVID-19), OPTION QUANTITY 1 STATISTICAL SUPPORT, OPTION QUANTITY 2 BIOSPECIMEN ANALYSIS, OPTION QUANTITY 3 REGULATORY SUPPORT, AND OPTION QUANTITY 4 GOVERNANCE LOGISTICS SUPPORT.
Ends
Sep 20, 2025
Started
Sep 21, 2022
Agency
National Institutes Of Health
NAICS
541380
75A50122F33003 ↗$0
BASE CONTRACT SERVICES TASK ORDER FOR CLINICAL STUDIES NETWORK (CSN) CLINICAL TRIAL PLANNING AND EXECUTION (CTPE) YEAR 3
Ends
Sep 26, 2025
Started
Sep 27, 2022
Agency
Office Of Assistant Secretary For Preparedness And Response
NAICS
541714
75N95020F00001 ↗$0
PHARMACOKINETIC ANALYSIS RESOURCE CENTER. TO3. NIDA REF. NO. N01DA-19-8947. PERIOD OF PERFORMANCE: 09/01/2020 TO 1/31/2025.
Ends
Oct 30, 2025
Started
Aug 31, 2020
Agency
National Institutes Of Health
NAICS
541715
75N95023F00001 ↗$0
PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 05/31/2025. NIDA REF. NO. N01DA-19-8947. CHANGE ORDER MODIFICATION.
Ends
Oct 30, 2025
Started
Aug 9, 2023
Agency
National Institutes Of Health
NAICS
541715
75A50123F33004 ↗$0
CLINICAL TRIAL PLANNING AND EXECUTION - COVID NEXT GENERATION VACCINE
Ends
Aug 20, 2028
Started
Aug 21, 2023
Agency
Office Of Assistant Secretary For Preparedness And Response
NAICS
541714
75A50120D00018 ↗$0
CLINICAL TRIALS PLANNING AND EXECUTION (TRI)
Ends
—
Started
Sep 27, 2020
Agency
Office Of Assistant Secretary For Preparedness And Response
NAICS
541714

PIID	Description	Agency	NAICS	Obligated	Start	End
75N93024C00004 ↗	CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS)	National Institutes Of Health	541715	$47.3M	Mar 31, 2024	Mar 30, 2027
75N93024F00001 ↗	NIAID/DAIDS REGULATORY SUPPORT CENTER	National Institutes Of Health	541714	$36.7M	Apr 14, 2024	Apr 13, 2027
75N91021C00013 ↗	CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.	National Institutes Of Health	541715	$19.4M	Jun 30, 2021	Jun 29, 2027
75N91022C00014 ↗	DRUG DEVELOPMENT SUPPORT FOR CTEP	National Institutes Of Health	541715	$16.2M	Jun 30, 2022	Jun 29, 2027
75N93022C00010 ↗	REGULATORY AFFAIRS SUPPORT	National Institutes Of Health	541715	$7.4M	Jun 30, 2022	Jun 29, 2027
75N93025F00001 ↗	DAIDS QUALITY ASSURANCE, QUALITY CONTROL AND INSPECTION READINESS SUPPORT SERVICES	National Institutes Of Health	541714	$5.8M	Apr 16, 2025	Apr 15, 2027
75N91022F00001 ↗	TASK ORDER 1A -PROJECT KICKOFF MEETING AND TASK ORDER 5A: CENTRALIZED PROTOCOL WRITING SUPPORT; CONTRACT TITLE: CANCER TRIALS SUPPORT UNIT CTSU.	National Institutes Of Health	541715	$831K	Jul 31, 2022	Jul 30, 2026
75N93023F00001 ↗	REGULATORY OPERATIONS SUPPORT SERVICES	National Institutes Of Health	541714	$569K	Mar 30, 2023	Mar 29, 2027
75N95025F00001 ↗	PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I SINGLE ASCENDING DOSE STUDY. MAY 15, 2025 - NOVEMBER 14, 2026. N01DA-25-8947. TASK ORDER 75N95025F00001 (TO1).	National Institutes Of Health	541715	$442K	May 14, 2025	Nov 13, 2026
75N93022F00001 ↗	'PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS (PTVDS)'	National Institutes Of Health	541715	$374K	Nov 30, 2021	Aug 6, 2027
75N94025F00001 ↗	NICHD:R&D:DATA COORDINATING CENTER FOR PREPARATION, TRAINING ACTIVITIES, ENROLLMENT AND DATA COLLECTION AND DATA ANALYSIS OF THE SPAN STUDY:NON-SEVERABLE	National Institutes Of Health	541714	$294K	Jul 31, 2025	Jul 30, 2026
75N95025F00003 ↗	PHARMACOKINETIC ANALYSIS RESOURCE CENTER. OTHER SUPPORT SERVICES. JULY 23, 2025 - JULY 22, 2026. N01DA-25-8947. TASK ORDER 75N95025F00003 (TO3).	National Institutes Of Health	541715	$36K	Jul 22, 2025	Jul 21, 2026
75N95024F00001 ↗	CHANGE ORDER. PHASE I SINGLE ASCENDING DOSE STUDY. TO7. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 09/10/2024 - 03/09/2026. NIDA REF. NO. N01DA-19-8947.	National Institutes Of Health	541715	$34K	Sep 9, 2024	Mar 7, 2027
75N94019F00125 ↗	NICHD:R&D:DATA COORDINATING CENTER FOR THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN):NON-SEVERABLE	National Institutes Of Health	541714	$11K	Sep 16, 2019	Jul 30, 2025
75N98026F00001 ↗	TASK ORDER 4. PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE III PROTOCOL (STP7). JUNE 5, 2026 - MARCH 4, 2027. N01DA-25-8947. TASK ORDER 75N98026F00001 (TO2).	National Institutes Of Health	541715	$11K	Jun 4, 2026	Mar 3, 2027
75N95025F00002 ↗	PHARMACOKINETIC ANALYSIS RESOURCE CENTER. PHASE I CLINICAL PHARMACOLOGY/PHARMACOKINETIC STUDY. JULY 23, 2025 - JANUARY 22, 2026. N01DA-25-8947. TASK ORDER 75N95025F00002 (TO2).	National Institutes Of Health	541715	$11K	Jul 22, 2025	Jul 30, 2026
GS00F274CA ↗	FEDERAL SUPPLY SCHEDULE CONTRACT	Federal Acquisition Service	541620	$0	Sep 15, 2015	—
75N93024F00002 ↗	DAIDS QUALITY ASSURANCE, QUALITY CONTROL AND INSPECTION READINESS SUPPORT SERVICES - CARRRP TASK AREA F	National Institutes Of Health	541714	$0	Apr 16, 2024	Apr 15, 2025
75N91024P00361 ↗	CLINICAL TRIALS ACCRUAL QUALITY IMPROVEMENT PROGRAM (AQUIP) DATA AND INFORMATION TECHNOLOGY SUPPORT FOR THE US-LATIN AMERICAN-CARIBBEAN HIV/HPV PREVENTION CLINICAL TRIALS NETWORK (ULACNET)	National Institutes Of Health	541990	$0	Jun 2, 2024	Jun 1, 2025
75N95022C00032 ↗	ACTIV-1 TIME-LIMITED BIOSPECIMEN STORAGE AND RELATED SERVICES (COVID-19), OPTION QUANTITY 1 STATISTICAL SUPPORT, OPTION QUANTITY 2 BIOSPECIMEN ANALYSIS, OPTION QUANTITY 3 REGULATORY SUPPORT, AND OPTION QUANTITY 4 GOVERNANCE LOGISTICS SUPPORT.	National Institutes Of Health	541380	$0	Sep 21, 2022	Sep 20, 2025
75A50122F33003 ↗	BASE CONTRACT SERVICES TASK ORDER FOR CLINICAL STUDIES NETWORK (CSN) CLINICAL TRIAL PLANNING AND EXECUTION (CTPE) YEAR 3	Office Of Assistant Secretary For Preparedness And Response	541714	$0	Sep 27, 2022	Sep 26, 2025
75N95020F00001 ↗	PHARMACOKINETIC ANALYSIS RESOURCE CENTER. TO3. NIDA REF. NO. N01DA-19-8947. PERIOD OF PERFORMANCE: 09/01/2020 TO 1/31/2025.	National Institutes Of Health	541715	$0	Aug 31, 2020	Oct 30, 2025
75N95023F00001 ↗	PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 05/31/2025. NIDA REF. NO. N01DA-19-8947. CHANGE ORDER MODIFICATION.	National Institutes Of Health	541715	$0	Aug 9, 2023	Oct 30, 2025
75A50123F33004 ↗	CLINICAL TRIAL PLANNING AND EXECUTION - COVID NEXT GENERATION VACCINE	Office Of Assistant Secretary For Preparedness And Response	541714	$0	Aug 21, 2023	Aug 20, 2028
75A50120D00018 ↗	CLINICAL TRIALS PLANNING AND EXECUTION (TRI)	Office Of Assistant Secretary For Preparedness And Response	541714	$0	Sep 27, 2020	—